Director Thompson sells ~293K shares over three days for $13.4M as stock rallies off lows but trails 52-week high.
Director Thompson Peter A. has sold nearly 293,000 shares totaling $13.4 million across three days in early May, representing his third consecutive wave of open-market sales in the trailing 36-month window. The timing is notable: the stock has rallied roughly 20% over the past three months and currently trades just below its 52-week high, yet the company remains unprofitable with ongoing quarterly losses. His prior sales at this ticker show mixed results—roughly half were well-timed exits that preceded stock declines, while the other half saw the stock rise afterward, suggesting inconsistent predictive value. The scale of this sale is material relative to his prior activity, though the unprofitable company's fundamentals and the stock's proximity to recent highs could suggest he is trimming holdings rather than expressing concern about near-term direction.
Director Orbimed Advisors Llc sells ~293k shares (~$13.4M) over three days as stock trades near its 52-week high.
Orbimed Advisors, a director at Sionna Therapeutics, disposed of roughly 293,000 shares across three trading days in early May, representing approximately 10% of their total holding and netting over $13 million. The timing is notable: the stock has rallied significantly over the prior quarter and trades near its 52-week high, a position where insiders often choose to lighten exposure. However, this director's own historical record at this company shows mixed timing on prior sales—about half of their previous exits saw the stock rise afterward (poorly timed exits), while the other half preceded stock declines (well-timed exits). The company itself remains unprofitable with substantial net losses and negative earnings, so this sale comes against the backdrop of fundamental weakness. Orbimed's filing history shows a clear pattern: 144 prior open-market sales across all holdings over the 36-month window, with this transaction representing the 145th-147th sale. The volume and frequency of sales relative to zero open-market purchases in the same period suggests this is a holder managing a large position, not an insider with accumulated operational conviction in the company.
Add SION to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.
